R1VT34.SA Revvity, Inc.

Healthcare Diagnostics & Research Sao Paulo Exchange
33.30 BRL
Close of Nov 5, 2026
14.90 33.39
Market cap
BRL 104B
P/E
79.3x
P/B
2.65x
ROE
2.6%
Dividend yield
0.11%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is R1VT34.SA undervalued?

Graham number

The Graham number of Revvity, Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Revvity, Inc. fundamental analysis

No fundamental analysis for Revvity, Inc. yet.

Revvity, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Revvity, Inc.

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for …

Full company profile